C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/55 (2006.01) A61K 38/46 (2006.01) C12N 9/16 (2006.01) C12N 9/22 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2211413
The present invention relates to amino acid sequence variants of human DNase I that have reduced binding affinity for actin. The invention provides nucleic acid sequences encoding such actin-resistant variants, thereby enabling the production of these variants in quantities sufficient for clinical use. The invention also relates to pharmaceutical compositions and therapeutic uses of actin-resistant variants of human DNase I.
L'invention concerne des variantes de séquences d'acides aminés de DNase I humaine présentant une affinité de liaison réduite vis-à-vis de l'actine. L'invention concerne des séquences d'acides nucléiques codant lesdites variantes résistantes à l'actine, permettant ainsi la production de ces variantes en quantités suffisantes pour une utilisation clinique. L'invention concerne également des compositions pharmaceutiques et des utilisations thérapeutiques de variantes de DNase I humaine résistantes à l'actine.
Lazarus Robert A.
Shak Steven
Ulmer Jana S.
Dennison Associates
Genentech Inc.
LandOfFree
Human dnase i variants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human dnase i variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human dnase i variants will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1668878